bioMerieux Ltd - Bacteriology managed service

The Norfolk and Norwich University Hospitals NHS Foundation Trust has concluded its tender process for a Bacteriology Managed Service, awarded to bioMerieux UK Limited. This contract encompasses services such as sample inoculation and incubation, digital imaging of culture plates, urine microscopy, organism identification, and antibiotic susceptibility testing. The procurement falls under the category of Bacteriological Analysis Services (CPV: 85111820) and is required to be delivered in the East of England region, specifically at postal code NR4 7UY.

85, commenced on 1st February 2025 and will run until 31st January 2032. The procurement method is listed as 'Other' and the tender process has been completed with all planning and tender stages finalised by the end of January 2025. This extensive contract offers significant growth opportunities for firms specialising in bacteriological and laboratory services, particularly those that can supply advanced technological solutions for medical diagnostics.

Businesses with capabilities in digital imaging, microscopy, and antimicrobial susceptibility testing will find this contract beneficial. Additionally, this opportunity is particularly well-suited for companies experienced in working within NHS frameworks and those looking to establish a substantial, long-term presence in the East of England's healthcare sector. SMEs are less likely to benefit as the contract does not specifically favour small or voluntary and community sector enterprises.